Hayley Gans

Publications

• Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age. Gans HA, Yasukawa LL, Sung P, Sullivan B, DeHovitz R, Audet S, Beeler J, Arvin AM. J Infect Dis. 2013; 207 (4): 574-82
• The status of live viral vaccination in early life. Gans HA, Vaccine. 2012
• Preterm infants' T cell responses to inactivated poliovirus vaccine. Klein NP, Gans HA, Sung P, Yasukawa LL, Johnson J, Sarafanov A, Chumakov K, Hansen J, Black S, Dekker CL. J Infect Dis. 2010; 201 (2): 214-22
• Age-related increase in the frequency of CD4(+) T cells that produce interferon-gamma in response to staphylococcal enterotoxin B during childhood. Hanna-Wakim R, Yasukawa LL, Sung P, Fang M, Sullivan B, Rinki M, DeHovitz R, Arvin AM, Gans HA. J Infect Dis. 2009; 200 (12): 1921-7
• Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. Gans HA, Yasukawa LL, Zhang CZ, Wakim RH, Rinki M, Dehovitz R, Arvin AM. Viral Immunol. 2008; 21 (2): 163-72
• Eosinophilic meningoencephalitis: psychiatric presentation and treatment. Hong DS, Bernstein M, Smith C, Gans H, Shaw RJ. Int J Psychiatry Med. 2008; 38 (3): 287-95
• Immune responses to mumps vaccine in adults who were vaccinated in childhood. Hanna-Wakim R, Yasukawa LL, Sung P, Arvin AM, Gans HA. J Infect Dis. 2008; 197 (12): 1669-75
• Primary vaccine failure after 1 dose of varicella vaccine in healthy children. Michalik DE, Steinberg SP, Larussa PS, Edwards KM, Wright PF, Arvin AM, Gans HA, Gershon AA. J Infect Dis. 2008; 197 (7): 944-9
• Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. Gans HA, Yasukawa LL, Alderson A, Rinki M, DeHovitz R, Beeler J, Audet S, Maldonado Y, Arvin AM. J Infect Dis. 2004; 190 (1): 83-90
• T cell immunity to measles viral proteins in infants and adults after measles immunization. Gans HA, Yasukawa LL, Alderson A, Rinki M, Dehovitz R, Maldonado Y, Arvin AM. Viral Immunol. 2004; 17 (2): 298-307
• Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Gans H, DeHovitz R, Forghani B, Beeler J, Maldonado Y, Arvin AM. Vaccine. 2003; 21 (24): 3398-405
• Jarisch-Herxheimer reaction associated with ciprofloxacin administration for tick-borne relapsing fever. Webster G, Schiffman JD, Dosanjh AS, Amieva MR, Gans HA, Sectish TC. Pediatr Infect Dis J. 2002; 21 (6): 571-3
• Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. Gans H, Yasukawa L, Rinki M, DeHovitz R, Forghani B, Beeler J, Audet S, Maldonado Y, Arvin AM. J Infect Dis. 2001; 184 (7): 817-26
• Intravenous ribavirin therapy for adenovirus pneumonia. Shetty AK, Gans HA, So S, Millan MT, Arvin AM, Gutierrez KM. Pediatr Pulmonol. 2000; 29 (1): 69-73
• IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. Gans HA, Maldonado Y, Yasukawa LL, Beeler J, Audet S, Rinki MM, DeHovitz R, Arvin AM. J Immunol. 1999; 162 (9): 5569-75
• Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. Gans HA, Arvin AM, Galinus J, Logan L, DeHovitz R, Maldonado Y. JAMA. 1998; 280 (6): 527-32